Bristol Myers discloses $39 million in Russia exit costs
Tweet
Share
E-mail
Test tubes are seen in front of a displayed Bristol Myers Squibb logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration
(Reuters) - Bristol Myers Squibb Co said on Wednesday it had transferred its commercial operations in Russia to a third-party distributor and incurred $39 million in related costs.
The drugmaker said in a filing that its remaining assets in the country were not material. (https://bit.ly/3PRxn5G)
(Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stripe’s OpenRouter deal signals a new race to control AI economics
- Hungary Paks nuclear plant could operate at full capacity by Wednesday, PM Magyar says
- ECB chief Lagarde 'ready to serve' WEF, Swiss newspaper reports
Create E-mail Alert Related Categories
General News, ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
